J. Nicholas Hoover

J. Nicholas Hoover

Senior Associate
Baltimore

Email nick.hoover@​hoganlovells.com

Phone +1 410 659 2790

Fax +1 410 659 2701

Practice groupCorporate

Nick Hoover counsels public and private companies on matters of varying complexity and sensitivity related to Securities and Exchange Commission disclosure, compliance with securities laws and regulations, equity and debt offerings, and corporate governance.

His transactional experience includes equity and debt financings that range from registered offerings – including IPOs, other underwritten offerings, registered direct offerings, and secondary offerings – to private placements of common and preferred equity and convertible and non-convertible notes. He also has experience with mergers and acquisitions and joint ventures.

Nick focuses in particular on helping life sciences companies navigate the unique needs of their industry, while also advising organizations in other fields, including technology, media, education, and aerospace and defense. Nick has worked with NYSE and Nasdaq listed entities ranging from smaller reporting and emerging growth companies to the Fortune 500.

Prior to becoming a lawyer, Nick wrote for an information technology news publication. Nick worked full time as a reporter during law school, receiving the University of Maryland's Larry P. Shoda award for scholastic excellence and special commitment required of evening students. During that time he was also executive articles editor for the Journal of Business and Technology Law.

Education and admissions

Education

J.D., University of Maryland, Francis King Carey School of Law, summa cum laude, Order of the Coif, 2013

M.A., American University, 2005

B.A., McDaniel College, 2003

Memberships

Member, Maryland Bar Association

Bar admissions and qualifications

Maryland

Representative experience

Advised NextCure, Inc. (Nasdaq: NXTC) on its US$86.25m initial public offering.

Advised Twenty-First Century Fox, Inc. on various debt offerings and corporate governance and disclosure matters.

Advised TESARO, Inc. on follow-on equity offerings, a convertible notes offering, corporate governance and disclosure matters, and its acquisition.

Advised Vaccinex, Inc. on its initial public offering.

Latest thinking and events

Hogan Lovells Publications

COVID-19 U.S.: Considerations for quarterly reports on Form 10-Q

Hogan Lovells Publications

Checklist: Form 10-K and proxy statement - Key changes and considerations for 2020 filing season

Published Works

Avoiding a Toxic Culture C-Suite: An Equilar Publication – Issue 30

Published Works

Can't You Smell that Smell: Clean Air Act Fixes for Factory Farm Air Pollution 6 Stanford Journal of Animal Law & Policy 1

Published Works

Compliance in the Ether: Cloud Computing, Data Security, and the Law 8 Journal of Business & Technology Law 255

Loading data